Robaxin-750 Disease Interactions
There are 2 disease interactions with Robaxin-750 (methocarbamol).
Methocarbamol (parenteral) (applies to Robaxin-750) renal dysfunction
Major Potential Hazard, Moderate plausibility.
The injectable formulation of methocarbamol is contraindicated for use in patients with impaired renal function due to the nephrotoxic potential of polyethylene glycol (PEG) 300 present in the vehicle. Quantities of PEG 300 much greater than that found in recommended doses of injectable methocarbamol have increased preexisting acidosis and urea retention in patients with renal impairment.
References
- "Product Information. Robaxin (methocarbamol)." Whitehall-Robbins
Methocarbamol (parenteral) (applies to Robaxin-750) seizures
Moderate Potential Hazard, Moderate plausibility.
Seizures have occurred during the intravenous administration of methocarbamol. In some cases, the patient had a known history of epilepsy, and the psychic trauma of the procedure may have been a contributing factor. Nevertheless, therapy with the injectable formulation of methocarbamol should be administered cautiously in patients with a history of epilepsy.
References
- "Product Information. Robaxin (methocarbamol)." Whitehall-Robbins
Robaxin-750 drug interactions
There are 343 drug interactions with Robaxin-750 (methocarbamol).
Robaxin-750 alcohol/food interactions
There is 1 alcohol/food interaction with Robaxin-750 (methocarbamol).
More about Robaxin-750 (methocarbamol)
- Robaxin-750 consumer information
- Check interactions
- Compare alternatives
- Reviews (41)
- Drug images
- Latest FDA alerts (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: skeletal muscle relaxants
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.